One of Europe's largest digital doctor apps is in talks to raise another €200m (£176m) from investors as the coronavirus pandemic accelerates demand for remote healthcare services.
Sky News has learnt that Kry, which trades as Livi in the UK, is working with bankers at JP Morgan on its Series D financing.
Sources close to investors who have been approached about the deal said that Kry, which is based in Stockholm, had shown impressive revenue growth during the past year.
Kry last raised external funding in January 2020, when it secured more than £100m in a round led by an arm of one of Canada's biggest pension funds.
Its valuation aspirations in the latest round were unclear on Friday.
The company attracted controversy in 2019 when it hired a senior NHS official who had written an article praising Kry without disclosing that she was to take a job there.
Livi allows patients to book a video appointment with GPs in a matter of minutes.
It also operates in countries such as France, Germany, Norway and Sweden and says it has booked nearly two million patient appointments across Europe.
The company competes with rivals such as Babylon, which has hundreds of millions of pounds from investors in recent years to fund its expansion.
A Kry spokesman declined to comment.
